Ophthalmology Doctors in Ashland, OR Accepting Medicare
7 Ophthalmology doctors found. Showing 1 - 7
 Dr. Jeffrey David Welder, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 648 N Main St, Ashland, OR 97520 Phone: 541-482-8100 |
 Dr. Vivian Schiedler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 251 Maple St, Ashland, OR 97520 Phone: 541-708-6393 Fax: 844-373-1899 |
Dr. John David Hyatt, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 246 Catalina Dr, Ashland, OR 97520 Phone: 541-488-3192 Fax: 541-488-0646 |
Dr. Robert Henry Ewing Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 648 N Main St, Ashland, OR 97520 Phone: 541-482-8100 Fax: 541-488-5081 |
Joshua Agranat, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 246 Catalina Dr, Ashland, OR 97520 Phone: 541-488-3193 |
Dr. Christine Read Gonzales, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 246 Catalina Dr, Ashland, OR 97520 Phone: 541-488-3192 Fax: 541-488-0646 |
Dr. William Stuart Epstein, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3530 Tolman Creek Rd, Ashland, OR 97520 Phone: 541-482-8100 Fax: 541-488-5081 |
News Archive
Trial finds similar five-year outcomes with transcatheter or surgical aortic valve replacement
New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality or stroke between patients at intermediate surgical risk who had transcatheter aortic valve replacement (TAVR) or surgery.
Recovery from single-site laparoscopy is less painful for kidney cancer patients
Researchers at the University of California, San Diego School of Medicine have found that recovery from an emerging, minimally invasive surgical technique called Laparo-Endoscopic Single-Site Surgery (LESS) was less painful for kidney cancer patients than traditional laparoscopic surgery.
UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.
Researchers identify a gut microbe generated byproduct linked to cardiovascular disease
Cleveland Clinic researchers have identified a gut microbe generated byproduct - phenylacetylglutamine - that is linked to development of cardiovascular disease, including heart attack, stroke and death.
› Verified 2 days ago
Family Medicine
Internal Medicine
Emergency Medicine
Psychiatry & Neurology
Ophthalmology
Obstetrics & Gynecology
Orthopaedic Surgery
Pediatrics